re: Ann: SPP Offer to Existing Eligible Share... "Good money after bad" that was exactly my response after receiving the phone call.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling